Man Collapses During Trump’s Oval Office Announcement
During a Thursday press conference in the Oval Office, a man suddenly collapsed behind President Donald Trump while discussing efforts to expand coverage and lower prices for obesity drugs Zepbound and Wegovy.
As the individual fainted, Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz supported his head while he was gently lowered to the floor. The cause of the collapse was not immediately clear.
White House press secretary Karoline Leavitt addressed the incident, stating:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Leavitt confirmed the man was a guest of one of the attending healthcare companies, Eli Lilly and Novo Nordisk. The collapsed man did not return to the event.
About an hour later, President Trump resumed the weight-loss drug event, mentioning the man had felt lightheaded but was now fine.
President Trump announced an agreement with Eli Lilly and Novo Nordisk to broaden Medicare coverage and reduce the cost of Zepbound and Wegovy, popular medications for obesity treatment.
Key Participants
- President Donald Trump
- Dr. Mehmet Oz, Centers for Medicare and Medicaid Services Administrator
- Karoline Leavitt, White House Press Secretary
- Representatives from Eli Lilly and Novo Nordisk
Newsweek has reached out to the White House for further comment.
Author’s summary: A man fainted during President Trump’s announcement on expanding coverage for obesity drugs but quickly recovered as the event continued with an agreement from major drugmakers.